Bristol Myers Squibb Stock Alpha and Beta Analysis
BMY Stock | USD 48.93 0.63 1.30% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Bristol Myers Squibb. It also helps investors analyze the systematic and unsystematic risks associated with investing in Bristol Myers over a specified time horizon. Remember, high Bristol Myers' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Bristol Myers' market risk premium analysis include:
Beta 0.75 | Alpha (0.08) | Risk 1.25 | Sharpe Ratio (0.01) | Expected Return (0.02) |
Bristol Myers Quarterly Cash And Equivalents |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Bristol |
Bristol Myers Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Bristol Myers market risk premium is the additional return an investor will receive from holding Bristol Myers long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Bristol Myers. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Bristol Myers' performance over market.α | -0.08 | β | 0.75 |
Bristol Myers expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Bristol Myers' Buy-and-hold return. Our buy-and-hold chart shows how Bristol Myers performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Bristol Myers Market Price Analysis
Market price analysis indicators help investors to evaluate how Bristol Myers stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bristol Myers shares will generate the highest return on investment. By understating and applying Bristol Myers stock market price indicators, traders can identify Bristol Myers position entry and exit signals to maximize returns.
Bristol Myers Return and Market Media
The median price of Bristol Myers for the period between Sat, Jan 20, 2024 and Fri, Apr 19, 2024 is 50.17 with a coefficient of variation of 3.27. The daily time series for the period is distributed with a sample standard deviation of 1.64, arithmetic mean of 50.24, and mean deviation of 1.39. The Stock received substential amount of media coverage during this period. Price Growth (%) |
Timeline |
Bristol Myers dividend paid on 1st of February 2024 | 02/01/2024 |
1 | Disposition of 1050 shares by Hoch Lynelle of Bristol Myers subject to Rule 16b-3 | 03/08/2024 |
2 | Bristol Myers drug Zeposia fails Phase 3 study for Crohns disease | 03/28/2024 |
3 | MaxCyte Signs Strategic Platform License with Be Biopharma to Support the Development of Engineered B Cell Medicines | 04/02/2024 |
4 | PureTech launches Seaport, hoping to create Karuna 2.0 | 04/09/2024 |
5 | 2 High-Yield Dividend Stocks Billionaires Are Buying Hand Over Fist | 04/10/2024 |
6 | Building a Better Future Bristol Myers Squibb 2023 ESG Report | 04/11/2024 |
7 | SHAREHOLDER ALERT Pomerantz Law Firm Investigates Claims on Behalf of Investors of Bristol-Myers Squibb Company - BMY | 04/12/2024 |
8 | Preclinical Safety Signal Prompts FDA Clinical Hold on Neumora Schizophrenia Drug | 04/15/2024 |
9 | Asher Bio Closes 55 Million Series C Financing to Advance Lead Program into Phase 1b Clinical Trials | 04/16/2024 |
10 | US FDA mandates label updates on CAR-T cancer therapies | 04/18/2024 |
About Bristol Myers Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Bristol or other stocks. Alpha measures the amount that position in Bristol Myers Squibb has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
2021 | 2022 | 2023 | 2024 (projected) | Dividend Yield | 0.0317 | 0.0302 | 0.0447 | 0.0374 | Price To Sales Ratio | 2.99 | 3.32 | 2.36 | 2.98 |
Bristol Myers Upcoming Company Events
As portrayed in its financial statements, the presentation of Bristol Myers' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Bristol Myers' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Bristol Myers' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Bristol Myers. Please utilize our Beneish M Score to check the likelihood of Bristol Myers' management manipulating its earnings.
2nd of February 2024 Upcoming Quarterly Report | View | |
25th of April 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
2nd of February 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Bristol Myers
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Bristol Myers Backtesting, Bristol Myers Valuation, Bristol Myers Correlation, Bristol Myers Hype Analysis, Bristol Myers Volatility, Bristol Myers History and analyze Bristol Myers Performance. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Complementary Tools for Bristol Stock analysis
When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Stocks Directory Find actively traded stocks across global markets | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Bristol Myers technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.